Zuvitere
Brand Name: ZUVITERE®-120
Composition: Docetaxel Injection I.P. Concentrate 120 mg(120mg/3ml)
Manufacturer: Zuvius Lifesciences (OncoAce Division)
Product Description
Medical Info
ZUVITERE®-120 is a specialized prescription oncology medication containing Docetaxel (120 mg/3 ml) as an injection concentrate. Belonging to the taxane class of chemotherapy agents, it works by binding to and stabilizing cellular microtubules, which prevents cancer cells from dividing and leads to their destruction. This potent medication is widely used in chemotherapy regimens to treat several advanced malignancies, including breast, non-small cell lung, prostate, gastric, and head and neck cancers. Because it can cause severe side effects such as bone marrow suppression, administration must be exclusively managed by an oncologist.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
